Sinopharm Group Co. Ltd (X2S) — Strategic Asset Allocation Index
Sinopharm Group Co. Ltd (X2S) has a Strategic Asset Allocation Index of 17.4% as of June 2023. Strategic assets (PP&E of €19.66 Billion plus long-term investments of €-) total €19.66 Billion, measured against net assets of €113.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Sinopharm Group Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Sinopharm Group Co. Ltd Strategic Asset Allocation Index (2013–2022)
This chart shows how Sinopharm Group Co. Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 17.4%, representing strategic assets of €19.66 Billion against net assets of €113.11 Billion EUR. For live market cap and overall valuation, see X2S market cap overview.
Annual Strategic Asset Allocation Index for Sinopharm Group Co. Ltd (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sinopharm Group Co. Ltd from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Sinopharm Group Co. Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.8% | €19.65 Billion | €19.65 Billion | €- | €110.07 Billion | ▼ -1.6 pp |
| 2021 | 19.5% | €19.41 Billion | €19.41 Billion | €- | €99.65 Billion | ▼ -1.5 pp |
| 2020 | 21.0% | €18.90 Billion | €18.90 Billion | €- | €89.95 Billion | ▼ -2.5 pp |
| 2019 | 23.5% | €18.06 Billion | €18.06 Billion | €- | €76.94 Billion | ▼ -3.0 pp |
| 2018 | 26.5% | €18.09 Billion | €11.03 Billion | €7.07 Billion | €68.28 Billion | ▼ -3.3 pp |
| 2017 | 29.8% | €15.29 Billion | €9.01 Billion | €6.28 Billion | €51.27 Billion | ▲ +6.1 pp |
| 2016 | 23.7% | €10.55 Billion | €6.75 Billion | €3.79 Billion | €44.53 Billion | ▲ +1.4 pp |
| 2015 | 22.3% | €9.10 Billion | €7.64 Billion | €1.46 Billion | €40.88 Billion | ▼ -0.8 pp |
| 2014 | 23.1% | €8.38 Billion | €7.10 Billion | €1.28 Billion | €36.29 Billion | ▼ -2.5 pp |
| 2013 | 25.6% | €7.32 Billion | €6.31 Billion | €1.01 Billion | €28.61 Billion | — |